James M. O’Brien
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James M. O’Brien
Earlier roles on record: CFO at Cognition Therapeutics Inc (CGTX) until August 12, 2022. Cognition Therapeutics Inc reported in an 8-K filed July 27, 2022 that James M. O’Brien was terminated as Chief Financial Officer, effective August 12, 2022. The proxy statement of Cognition Therapeutics Inc reports total compensation of $696,241 for James M. O’Brien in fiscal 2022, including a base salary of $253,372. Disclosed compensation is on record for 3 fiscal years.
“On July 21, 2022, Cognition Therapeutics, Inc. (the "Company") determined that James O'Brien, the Company's Chief Financial Officer, will be leaving the Company as of August 12, 2022 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2022-08-12
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Cognition Therapeutics Inc (CGTX) | Former Chief Financial Officer | $253,372 | $696,241 |
| 2021 | Cognition Therapeutics Inc (CGTX) | Former Chief Financial Officer | $348,769 | $1,038,156 |
| 2020 | Cognition Therapeutics Inc (CGTX) | Chief Financial Officer | $340,000 | $418,213 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.